NIH In Talks With Pfizer To Study Whether Longer Course Of Paxlovid Is Needed To Prevent Reinfections

May 19, 2022

Reuters (5/18, Erman) reports “the U.S. National Institutes of Health is in talks with Pfizer Inc about studying whether a longer course of the drugmaker’s COVID-19 antiviral treatment Paxlovid is needed to prevent reinfections...said” NIAID Director Dr....